Daw JR, Hatfield LA. 2018. Matching and regression to the mean in difference-in-differences analysis. Health Services Research, Early View.
Daw JR, Hatfield LA. 2018. Matching in difference-in-differences: between a rock and a hard place. Health Services Research, Early View.
Daw JR, Sommers BD. 2018. Association of the Affordable Care Act dependent coverage provision with prenatal care use and birth outcomes. JAMA 319(6): 579-587.
Daw JR, Sommers BD. 2017. Pregnancy, immigration, and health insurance: new evidence and ongoing debate. Obstetrics & Gynecology 130(5): 935-937.
Daw JR, Hatfield LA, Swartz K, Sommers BD. 2017. Women in the United States experience high rates of insurance coverage ‘churn’ in months before and after childbirth. Health Affairs 36(4): 598-606.*One of the Editor’s Top 10 articles of the year in Health Affairs*
Edelstein C, Daw JR, Kassam Z. 2016. Seeking safe stool: Canada needs a universal donor model. Canadian Medical Association Journal 188(17-18): E431-432.
Edelstein C, Kassam Z, Daw JR, Smith MB, Kelly CR. 2015. The regulation of fecal microbiota transplantation: navigating policy and public health. Clinical Research and Regulatory Affairs 32(3): 101-109.
Morgan SG, Law MR, Daw JR, Abraham L, Martin D. 2015. Estimated cost of universal public coverage of prescription drugs in Canada. Canadian Medical Association Journal 187: 491-497. *Winner of the CIHR-ISHPR 2015-2016 Article of the Year Award and the 2016 CMAJ Bruce Squires Award*
Daw JR, Morgan SG, Collins PA, Abelson J. 2014. Framing incremental expansions to public health insurance programs: the case of Canadian pharmacare. Journal of Health Politics, Policy, and Law 39(2): 295-330.
Puyat J, Daw JR, Morgan SG, Law MR, Cunningham CC, Wong S. 2013. Ethnic disparities in the use of antipsychotics: a systematic review and meta-analysis. Social Psychiatry and Psychiatric Epidemiology 48(12): 1861-72.
Morgan SG, Thomson PT, Daw JR, Friesen MK. 2013. Canadian policy makers’ views on pharmaceutical reimbursement contracts involving confidential discounts from drug manufacturers. Health Policy 112(3): 248-54.
Morgan SG, Friesen MK, Thomson PT, Daw JR. 2013. Use of product listing agreements by provincial drug benefit plans. Healthcare Policy 8(4): 45-55.
Morgan SG, Daw JR, Thomson PA. 2013. International best practices for negotiating ‘reimbursement contracts’ with price rebates from pharmaceutical companies. Health Affairs 32(4): 771-777.
Law MR, Daw JR, Cheng L, Morgan SG. 2013. Growth in private payments for health care by Canadian households. Health Policy 110(2): 141-146.
Daw JR, Morgan SG, Thomson PA, Law MR. 2013. Here today, gone tomorrow: the issue attention cycle and national print media coverage of prescription drug financing in Canada. Health Policy 110(1): 67-75.
Morgan SG, Thomson PT, Daw JR, Friesen MK. 2013. Inter-jurisdictional co-operation on pharmaceutical product listing agreements: lessons from Canada. BMC Health Services Research 13:34.
Morgan SG, Daw JR. 2012. Canadian pharmacare: looking back, looking forward. Healthcare Policy8(1): 17-25.
Daw JR, Morgan SG. 2012. Stitching the gaps in the Canadian public drug coverage patchwork? A review of provincial pharmacare policy changes 2000-2010. Health Policy 104(1): 19-26.
Daw JR, Mintzes B, Law MR, Hanley GE, Morgan SG. 2012. Prescription drug use in pregnancy: a retrospective population-based study in British Columbia, Canada (2001-2006). Clinical Therapeutics 34(1): 239-249.
Daw JR, Hanley GE, Greyson DG, Morgan SG. 2011. Prescription drug use during pregnancy in developedcountries: a systematic review. Pharmacoepidemiology and Drug Safety 20(9): 895-902.
Morgan SG, Daw JR,Thomson PA. 2014. Pharmaceuticals. In Marchildon GP, Di Matteo L (Eds), Bending the Cost Curve in Health Care: Canada’s Provinces in International Perspective. The Johnson-Shoyama Series on Public Policy. University of Toronto Press: Toronto.
Reports for Government and Think-Tanks
Morgan SG, Daw JR, Law MR. 2014. Are income-based public drug benefit programs fit for an aging population? Institute for Research on Public Policy Research. Study No. 50. [peer-reviewed]
Morgan SG, Daw JR, Law MR. 2013. Rethinking pharmacare in Canada. C.D. Howe Institute. Study No. 384. [peer-reviewed]
Daw JR, Law MR, Cheng L, Morgan SG. 2011. Catastrophic out-of-pocket spending on prescription medicines in Canada. Commissioned by The Office of Pharmaceuticals Management Strategies, Strategic Policy Branch, Health Canada.
Daw JR. 2009. Personalized medicine: issues for Canadian pharmaceuticals management. Prepared for The Office of Pharmaceuticals Management Strategies, Strategic Policy Branch, Health Canada.